Rupal H Trivedi1, M Edward Wilson2. 1. From the Miles Center for Pediatric Ophthalmology, Storm Eye Institute, Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, USA. Electronic address: trivedi@musc.edu. 2. From the Miles Center for Pediatric Ophthalmology, Storm Eye Institute, Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, USA.
Abstract
PURPOSE: To compare the rate of visually significant posterior capsule opacification (PCO) in pediatric eyes with and without traumatic cataract. SETTING: Storm Eye Institute, Charleston, South Carolina, USA. DESIGN: Retrospective case control study. METHODS: Eyes operated on for traumatic cataract and having in-the-bag single-piece hydrophobic intraocular lens (IOL) implantation were identified. The control group of eyes operated on for nontraumatic cataract was matched with reference to age, management of the posterior capsule, type of IOL, and follow-up duration. RESULTS: Data from 58 eyes were studied. Age at surgery was comparable between the study group and the control group (7.3 versus 7.8 years) (P = .7). The rate of PCO was statistically significantly different between the 2 groups (12/29 eyes versus 2/29 eyes) (P = .002). This difference was more marked for those with intact posterior capsules (9/12 eyes [75%] and 1/12 eyes [8%] (P = .001) compared with eyes with primary posterior capsulectomy and vitrectomy (3/17 [18%] and 1/17 [6%] (P = .6). For eyes with intact posterior capsules, the duration between cataract surgery and intervention for PCO was 4 to 15 months in the traumatic cataract group; 1 eye in the nontraumatic cataract group required intervention 20 months after surgery. CONCLUSIONS: Eyes with traumatic cataract were more likely to develop PCO than eyes without traumatic cataract. The results also suggest that PCO develops faster in eyes with traumatic cataract. Primary posterior capsulectomy and vitrectomy should be considered for children having traumatic cataract surgery, irrespective of age at the time of surgery. FINANCIAL DISCLOSURE: Neither author has a financial or proprietary interest in any material or method mentioned.
PURPOSE: To compare the rate of visually significant posterior capsule opacification (PCO) in pediatric eyes with and without traumatic cataract. SETTING: Storm Eye Institute, Charleston, South Carolina, USA. DESIGN: Retrospective case control study. METHODS: Eyes operated on for traumatic cataract and having in-the-bag single-piece hydrophobic intraocular lens (IOL) implantation were identified. The control group of eyes operated on for nontraumatic cataract was matched with reference to age, management of the posterior capsule, type of IOL, and follow-up duration. RESULTS: Data from 58 eyes were studied. Age at surgery was comparable between the study group and the control group (7.3 versus 7.8 years) (P = .7). The rate of PCO was statistically significantly different between the 2 groups (12/29 eyes versus 2/29 eyes) (P = .002). This difference was more marked for those with intact posterior capsules (9/12 eyes [75%] and 1/12 eyes [8%] (P = .001) compared with eyes with primary posterior capsulectomy and vitrectomy (3/17 [18%] and 1/17 [6%] (P = .6). For eyes with intact posterior capsules, the duration between cataract surgery and intervention for PCO was 4 to 15 months in the traumatic cataract group; 1 eye in the nontraumatic cataract group required intervention 20 months after surgery. CONCLUSIONS: Eyes with traumatic cataract were more likely to develop PCO than eyes without traumatic cataract. The results also suggest that PCO develops faster in eyes with traumatic cataract. Primary posterior capsulectomy and vitrectomy should be considered for children having traumatic cataract surgery, irrespective of age at the time of surgery. FINANCIAL DISCLOSURE: Neither author has a financial or proprietary interest in any material or method mentioned.
Authors: Erick D Bothun; Michael X Repka; Trevano W Dean; Michael E Gray; Phoebe D Lenhart; Zhuokai Li; David G Morrison; David K Wallace; Raymond T Kraker; Susan A Cotter; Jonathan M Holmes Journal: JAMA Ophthalmol Date: 2021-06-01 Impact factor: 7.389